Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
MINJUVI Trockensub 200 mg Durchstf
Drug
Minjuvi, poudre pour solution à diluer pour perfusion
diffuses grosszelliges B-Zell Lymphom (DLBCL)
07.16.1. – cytostatics
HAM – Human medicine
PULPI – powder for concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
3/22/2022
5/20/2030
Dosage strength
Minjuvi 200 mg, poudre pour solution à diluer pour perfusion
lymphome diffus à grandes cellules B (DLBCL)
01
Z – approved
Package
7680680830017
In trade from / since 3/22/2022
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component Freeze-dried preparation
200 mg tafasitamabum
natrii citras dihydricus
7.4 mg natrium
acidum citricum monohydricum
trehalosum dihydricum
polysorbatum 20
7.4 mg natrium
acidum citricum monohydricum
trehalosum dihydricum
polysorbatum 20
Spezialitätenliste***
SL
-
-
754.15
None
Yes
10%
No
Authorisation holder
7601001399150
Incyte Biosciences International
Rue Docteur-Yersin 12
1110 Morges (VD)
Rue Docteur-Yersin 12
1110 Morges (VD)
Date of revision of the text
6/1/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.